Latest Trials Latest NewsFAQ

UNIVERSITY OF MINNESOTA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-01

Employees: 10K

Market Cap: -

Website: http://www.umn.edu

Clinical Trials

Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System

Terminated

Conditions: Anesthesia

Interventions: Device: TwitchView EMG Unit
Device: Novel QTOF Device

First Posted Date: 2020-05-28

Last Posted Date: 2023-02-22

Lead Sponsor: University of Minnesota

Target Recruit Count: 9

Registration Number: NCT04406740

Locations: 🇺🇸
MHealth Farview University of Minnesota Medical Center, Minneapolis, Minnesota, United States

The Professional Peer Resilience Initiative

Conditions: Secondary Traumatic Stress
Professional Quality of Life
Stress Related Disorder
Mental Resilience
Stress Risk
Emotional Resilience
Stress
Stress, Psychological
Trauma, Psychological
Anxiety State

Interventions: Behavioral: MinnRAP Peer Support Program

First Posted Date: 2020-05-20

Last Posted Date: 2023-09-25

Lead Sponsor: University of Minnesota

Target Recruit Count: 1200

Registration Number: NCT04396600

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Recurrent Hypoglycemia in Type 1 Diabetes (Aim 2)

Not Applicable

Active, not recruiting

Conditions: Diabetes Mellitus, Type 1

Interventions: Other: Experimental hyperglycemia

First Posted Date: 2020-05-13

Last Posted Date: 2024-05-16

Lead Sponsor: University of Minnesota

Target Recruit Count: 50

Registration Number: NCT04387422

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

Phase 4

Completed

Conditions: Anesthesia
Pain
Pain, Acute

Interventions: Drug: Sublingual Sufentanil

First Posted Date: 2020-05-13

Last Posted Date: 2022-06-28

Lead Sponsor: University of Minnesota

Target Recruit Count: 53

Registration Number: NCT04387136

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

International SARS-CoV-2 (COVID-19) Infection Observational Study

Completed

Conditions: SARS-CoV 2
Dyspnea
COVID19
COVID

Interventions: Other: Data Collection

First Posted Date: 2020-05-12

Last Posted Date: 2022-08-16

Lead Sponsor: University of Minnesota

Target Recruit Count: 11973

Registration Number: NCT04385251

Locations: 🇦🇷
Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos, Buenos Aires, Argentina
🇺🇸
Denver Public Health, Denver, Colorado, United States
🇬🇧
University College London Medical School Centre for Sexual Health and HIV Research, London, England, United Kingdom

and more 1 locations

Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course

Completed

Conditions: PANDAS
PANS

Interventions: Other: No intervention

First Posted Date: 2020-05-11

Last Posted Date: 2020-05-11

Lead Sponsor: University of Minnesota

Target Recruit Count: 22

Registration Number: NCT04382716

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

Phase 1

Active, not recruiting

Conditions: Spinal Cord Injuries

Interventions: Drug: Brivaracetam
Other: Placebo

First Posted Date: 2020-05-07

Last Posted Date: 2024-05-03

Lead Sponsor: University of Minnesota

Target Recruit Count: 24

Registration Number: NCT04379011

Locations: 🇺🇸
University of Minnesota School of Medicine, Minneapolis, Minnesota, United States
🇺🇸
Swedish Hospital, Englewood, Colorado, United States

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

Completed

Conditions: Coronavirus Infection
Covid-19
COVID
SARS-CoV-2

Interventions: Diagnostic Test: Point-of-Care Ultrasonography (POCUS)

First Posted Date: 2020-04-09

Last Posted Date: 2023-01-04

Lead Sponsor: University of Minnesota

Target Recruit Count: 129

Registration Number: NCT04339998

Locations: 🇺🇸
University of Minnesota Medical Center (UMMC), Minneapolis, Minnesota, United States
🇺🇸
M Health Fairview Bethesda Hospital, Saint Paul, Minnesota, United States

Pre-exposure Prophylaxis for SARS-Coronavirus-2

Phase 3

Completed

Conditions: Corona Virus Infection
Acute Respiratory Distress Syndrome
COVID-19
ARDS

Interventions: Other: Placebo
Drug: Hydroxychloroquine

First Posted Date: 2020-03-31

Last Posted Date: 2021-07-02

Lead Sponsor: University of Minnesota

Target Recruit Count: 1483

Registration Number: NCT04328467

Locations: 🇺🇸
Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

Phase 2

Withdrawn

Conditions: Pruritus
Atopic Dermatitis
Dermatitis
Pruritus Chronic

Interventions: Drug: Naltrexone
Other: Placebo

First Posted Date: 2020-03-30

Last Posted Date: 2023-04-04

Lead Sponsor: University of Minnesota

Registration Number: NCT04325802

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy